DIVINHEALSimplifying Global Wellbeing
HOME
TREATMENTS
HOSPITALS
Page background

PGT-A/PGT-M (Genetic Testing of Embryos) Success Rate in Haryana

Content updated at: February 19, 2026

About

```html

Understanding PGT-A/PGT-M Success Rate in Haryana

For individuals and couples considering advanced reproductive technologies, understanding the PGT-A/PGT-M (Genetic Testing of Embryos) success rate in Haryana is crucial. These tests aim to identify embryos free from specific genetic conditions or chromosomal abnormalities before uterine transfer. Outcomes for PGT-A/PGT-M are influenced by numerous factors, including parental age, embryo quality, and the specific genetic concern being addressed, providing an essential context for prospective parents.

In Haryana, PGT-A/PGT-M success rates are assessed by analyzing aggregated clinical data from leading fertility centers across the region. This evaluation considers the efficacy of genetic screening in selecting viable embryos. It's important to recognize that individual patient profiles significantly impact overall outcomes, necessitating a personalized understanding of success metrics.

Defining Success in PGT-A/PGT-M Genetic Testing

For PGT-A/PGT-M, "success" is multifaceted. Initially, it refers to the accurate identification of euploid (chromosomally normal) or unaffected embryos suitable for transfer. The ultimate goal, however, is achieving a successful live birth following the transfer of such embryos. This distinguishes diagnostic success from the clinical outcome, providing a comprehensive understanding of the PGT-A/PGT-M (Genetic Testing of Embryos) survival rate in Haryana within the broader fertility journey.

PGT-A/PGT-M (Genetic Testing of Embryos) Outcome Breakdown

Outcomes for PGT-A/PGT-M vary significantly based on the specific test, underlying genetic condition, and characteristics of the patient's embryos.

Treatment Type / Category Typical Use Case Identification Rate Range (%) What Success Indicates
PGT-A (Aneuploidy) Screening for chromosomal abnormalities 60%–85% Identification of euploid embryos suitable for transfer
PGT-M (Monogenic) Screening for specific single gene disorders 95%–99% Identification of embryos unaffected by the disorder
PGT-SR (Structural Rearrangements) Screening for balanced chromosomal translocations 65%–80% Identification of balanced/normal embryos for transfer

PGT-A/PGT-M (Genetic Testing of Embryos) Survival Rate by Age in Haryana

Maternal age is a dominant factor influencing the success of PGT-A, primarily due to the increased incidence of aneuploidy in older women's oocytes. This directly affects the availability of euploid embryos for transfer, impacting pregnancy chances. These trends in Haryana align with internationally observed clinical data, where younger maternal age correlates with a higher yield of healthy embryos. Understanding the stage wise PGT-A/PGT-M (Genetic Testing of Embryos) survival rate in Haryana also considers embryo developmental stage at biopsy.

Maternal Age Group Euploid Embryo Yield Rate (%) Live Birth Rate per Transfer (%)
Under 35 years 45%–65% 50%–65%
35–37 years 35%–55% 40%–55%
38–40 years 20%–40% 25%–40%
Over 40 years 10%–25% 10%–25%

Haryana's PGT-A/PGT-M Outcomes: A Global Perspective

Success rates for PGT-A/PGT-M in Haryana are often comparable with international benchmarks, particularly in centers adopting advanced laboratory techniques and stringent clinical protocols. These outcomes reflect similar trends observed worldwide under equivalent conditions of patient selection and technological application.

Region Live Birth Rate per PGT-A/PGT-M Embryo Transfer (%)
India (Haryana) 35%–55%
North America 40%–60%
Western Europe 38%–58%
Australia & New Zealand 42%–62%
East Asia 37%–57%

The success rates presented are indicative averages and not guarantees. Individual outcomes can vary significantly based on specific patient conditions, the chosen treatment approach, and clinic-specific factors.

Factors Influencing PGT-A/PGT-M Success Trends

  • Maternal age, significantly impacting embryo euploidy rates and the PGT-A/PGT-M (Genetic Testing of Embryos) recovery rate in Haryana.
  • Quality and number of retrieved oocytes and embryos available for biopsy.
  • The specific genetic condition being screened for in PGT-M.
  • Laboratory expertise in embryo biopsy and genetic analysis techniques.
  • Embryo culture conditions and the precise timing and skill of embryo transfer.
  • Underlying causes of infertility or recurrent pregnancy loss.
  • Previous IVF cycle outcomes and patient medical history.

Data Sources and Methodology for PGT-A/PGT-M Outcomes

  • National and international fertility registries, such as those maintained by the Indian Council of Medical Research (ICMR) and organizations like ESHRE and SART.
  • Peer-reviewed scientific publications and studies conducted in the field of reproductive medicine and genetics.
  • Aggregated clinical data from reputable fertility clinics and research institutions across India and globally.
  • Large-scale cohort studies focused on assisted reproductive technologies and their efficacy. Leading medical and research institutions in India adhere to evidence-based protocols for advanced reproductive technologies.

Empowering Confident Healthcare Decisions

Understanding PGT-A/PGT-M outcomes provides valuable insights for family planning. Patients are encouraged to engage in thorough discussions with fertility specialists to personalize their treatment journey with realistic expectations and informed choices.

```

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Meet Our Doctors

Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.

Dr. Aditya Gupta

Dr. Aditya Gupta

Chairperson - Neurosurgery & CNS Radiosurgery & Co-Chief - Cyberknife Centre, Artemis Hospitals, Gurgaon

Neurosurgeon

Haryana

32+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Abhinandan Mukhopadhyay

Dr. Abhinandan Mukhopadhyay

Sr. Consultant - Urology & Kidney Transplant Program (Unit I)

Urology, Kidney Transplant, Urological Cancers

Haryana

8+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Aditi Dixit

Aditi Dixit

Sr. Consultant – Women Imaging

Radiology (Specializing in Women's Imaging)

Haryana

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Ajit Singh Baghela

Dr. Ajit Singh Baghela

Consultant

Paediatric Neurology

Haryana

9+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Amit Jassal

Amit Jassal

Sr. Consultant - Anaesthesia

Anaesthesia

Haryana

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Amit Kumar Chaurasia

Dr. Amit Kumar Chaurasia

Chief Cath Lab & TAVI (Unit I), Director TAVI/TAVR and Structural Heart Disease and Senior Consultant Cardiology

Cardiology, Interventional Cardiology, TAVI / TAVR & Structural Heart Diseases

New Delhi

16+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Anjana Kharbanda

Anjana Kharbanda

Sr. Consultant - Emergency

Emergency & Trauma Services

New Delhi

22+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. (Col) B Kalra

Dr. (Col) B Kalra

Associate Chief - Cardiology (NIC)

Cardiology

New Delhi

18+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. D.K. Jhamb

Dr. D.K. Jhamb

Chief Cardiology (Unit IV)

Cardiology

New Delhi

30+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr Amit Jassal

Dr Amit Jassal

Principal Consultant - Anaesthesia

Anaesthesia

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details

Related Links

Ready To Start Your Healing Journey?

Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.